Sigilon Therapeutics Inc (SGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,608 | -39,419 | -26,225 | -12,735 | -43,925 |
| Depreciation Amortization | 854 | 628 | 410 | 202 | 675 |
| Accounts receivable | -41 | 69 | 3 | -168 | N/A |
| Accounts payable and accrued liabilities | -467 | -1,304 | 624 | 2,355 | N/A |
| Other Working Capital | -15,460 | -10,395 | -8,589 | -4,121 | -10,890 |
| Other Operating Activity | 8,074 | 5,896 | 2,268 | -735 | 4,066 |
| Operating Cash Flow | $-61,648 | $-44,525 | $-31,509 | $-15,202 | $-50,074 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -972 | -477 | -256 | -190 | -1,209 |
| Investing Cash Flow | $-972 | $-477 | $-256 | $-190 | $-1,209 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 19,788 | 19,788 | N/A | N/A | N/A |
| Debt Repayment | -15,000 | -15,000 | N/A | N/A | N/A |
| Common Stock Issued | 132,527 | 164 | 146 | 121 | N/A |
| Other Financing Activity | 52,082 | 26,698 | 26,922 | 26,945 | 63,242 |
| Financing Cash Flow | $189,397 | $31,650 | $27,068 | $27,066 | $63,242 |
| Beginning Cash Position | 76,645 | 76,645 | 76,645 | 76,645 | 64,686 |
| End Cash Position | 203,422 | 63,293 | 71,948 | 88,319 | 76,645 |
| Net Cash Flow | $126,777 | $-13,352 | $-4,697 | $11,674 | $11,959 |
| Free Cash Flow | |||||
| Operating Cash Flow | -61,648 | -44,525 | -31,509 | -15,202 | -50,074 |
| Capital Expenditure | -972 | -477 | -256 | -190 | N/A |
| Free Cash Flow | -62,620 | -45,002 | -31,765 | -15,392 | -50,074 |